These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 171964)

  • 41. Effect of PTH and 1,25(OH)2D3 on renal 25(OH)D3 metabolism, adenylate cyclase, and protein kinase.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Am J Physiol; 1984 Jan; 246(1 Pt 1):E102-7. PubMed ID: 6320659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.
    Heath H; Purnell DC
    J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 22-Oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretion.
    Friedlaender MM; Yagil Y; Wald H; Popovtzer MM
    Bone; 1995 Sep; 17(3):301-6. PubMed ID: 8541145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition by prostaglandin E2 of renal effects of calcitonin in rats.
    Yamada M; Matsumoto T; Su KW; Ogata E
    Endocrinology; 1985 Feb; 116(2):693-7. PubMed ID: 3855398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parameters of evaluation and correlation of renal phosphate handling and of parathyroid function in children.
    Stark H; Eisenstein B; Davidovits M
    Nephron; 1989; 51(4):478-81. PubMed ID: 2544818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Jejunal phosphate transport is not regulated by the PTH-adenylate cyclase system. Further studies on the contrasting features between intestinal and renal phosphate transport mechanisms.
    Lee DB; Walling MW; Palant CE; Tallos E
    Miner Electrolyte Metab; 1986; 12(5-6):293-7. PubMed ID: 3027518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets.
    Even L; Weisman Y; Goldray D; Hochberg Z
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2836-40. PubMed ID: 8768839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phosphaturic effect of PTH during hypoxia and hypocapnia in rats].
    Mimura Y
    Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):637-46. PubMed ID: 7796927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R; Moses AM
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of acute hypercapnia on PTH-stimulated phosphaturia in dietary Pi-deprived rat.
    Guntupalli J; Matthews B; Carlin B; Bourke E
    Am J Physiol; 1987 Jul; 253(1 Pt 2):F34-40. PubMed ID: 3037923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of 1, 25 dihydroxycholecalciferol (1, 25-(OH) 2-D3) to modify cyclic AMP levels in parathyroid hormone-treated and untreated bone cells.
    Peck WA; Dowling I
    Endocr Res Commun; 1976; 3(2):157-66. PubMed ID: 182450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An investigation of calcium intake, 1-alpha(OH)D3, and etidronate on bone.
    Menczel J; Singer L; Ophaug RH
    Bone; 1987; 8(2):91-4. PubMed ID: 3036192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired renal response to parathyroid hormone in potassium depletion.
    Beck N; Davis BB
    Am J Physiol; 1975 Jan; 228(1):179-83. PubMed ID: 167590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of antibody to renal plasma membrane on urinary excretion of adenosine 3',5'-monophosphate and phosphate induced by parathyroid hormone infusion in rats.
    Yamada K; Saito Y; Tamura Y; Yamamoto M; Kumagai A
    Endocrinology; 1980 Mar; 106(3):973-8. PubMed ID: 6243559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human parathyroid hormone inhibits renal 24-hydroxylase activity of 25-hydroxyvitamin D3 by a mechanism involving adenosine 3',5'-monophosphate in rats.
    Shigematsu T; Horiuchi N; Ogura Y; Miyahara T; Suda T
    Endocrinology; 1986 Apr; 118(4):1583-9. PubMed ID: 3004922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of hypocalcemia on renal phosphorus handling in the rat: interaction with dietary phosphorus and PTH.
    Guntupalli J; Bourke E
    Miner Electrolyte Metab; 1989; 15(4):201-8. PubMed ID: 2548070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status.
    Llach F; Coburn JW; Brickman AS; Kurokawa K; Norman AW; Canterbury JM; Reiss E
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1054-60. PubMed ID: 194908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.